Ubiquitous health profile (UHPr): a big data curation platform for supporting health data interoperability

The lack of Interoperable healthcare data presents a major challenge, towards achieving ubiquitous health care. The plethora of diverse medical standards, rather than common standards, is widening the gap of interoperability. While many organizations are working towards a standardized solution, there is a need for an alternate strategy, which can intelligently mediate amongst a variety of medical systems, not complying with any mainstream healthcare standards while utilizing the benefits of several standard merging initiates, to eventually create digital health personas. The existence and efficiency of such a platform is dependent upon the underlying storage and processing engine, which can acquire, manage and retrieve the relevant medical data. In this paper, we present the Ubiquitous Health Profile (UHPr), a multi-dimensional data storage solution in a semi-structured data curation engine, which provides foundational support for archiving heterogeneous medical data and achieving partial data interoperability in the healthcare domain. Additionally, we present the evaluation results of this proposed platform in terms of its timeliness, accuracy, and scalability. Our results indicate that the UHPr is able to retrieve an error free comprehensive medical profile of a single patient, from a set of slightly over 116.5 million serialized medical fragments for 390,101 patients while maintaining a good scalablity ratio between amount of data and its retrieval speed.N/

Secretion of Rhoptry and Dense Granule Effector Proteins by Nonreplicating <i>Toxoplasma gondii</i> Uracil Auxotrophs Controls the Development of Antitumor Immunity

<div><p>Nonreplicating type I uracil auxotrophic mutants of <i>Toxoplasma gondii</i> possess a potent ability to activate therapeutic immunity to established solid tumors by reversing immune suppression in the tumor microenvironment. Here we engineered targeted deletions of parasite secreted effector proteins using a genetically tractable Δ<i>ku80</i> vaccine strain to show that the secretion of specific rhoptry (ROP) and dense granule (GRA) proteins by uracil auxotrophic mutants of <i>T</i>. <i>gondii</i> in conjunction with host cell invasion activates antitumor immunity through host responses involving CD8α⁺ dendritic cells, the IL-12/interferon-gamma (IFN-γ) T_H1 axis, as well as CD4⁺ and CD8⁺ T cells. Deletion of parasitophorous vacuole membrane (PVM) associated proteins ROP5, ROP17, ROP18, ROP35 or ROP38, intravacuolar network associated dense granule proteins GRA2 or GRA12, and GRA24 which traffics past the PVM to the host cell nucleus severely abrogated the antitumor response. In contrast, deletion of other secreted effector molecules such as GRA15, GRA16, or ROP16 that manipulate host cell signaling and transcriptional pathways, or deletion of PVM associated ROP21 or GRA3 molecules did not affect the antitumor activity. Association of ROP18 with the PVM was found to be essential for the development of the antitumor responses. Surprisingly, the ROP18 kinase activity required for resistance to IFN-γ activated host innate immunity related GTPases and virulence was not essential for the antitumor response. These data show that PVM functions of parasite secreted effector molecules, including ROP18, manipulate host cell responses through ROP18 kinase virulence independent mechanisms to activate potent antitumor responses. Our results demonstrate that PVM associated rhoptry effector proteins secreted prior to host cell invasion and dense granule effector proteins localized to the intravacuolar network and host nucleus that are secreted after host cell invasion coordinately control the development of host immune responses that provide effective antitumor immunity against established ovarian cancer.</p></div